PFE
Pfizer Inc.
Healthcare · Drug Manufacturers - General
Last price
US$ 25,01
▲ 0,40% on 31/07/2026
Fundamentals
Indicators
P/L
18,39
Relação entre o preço da ação e o lucro por ação (LPA) informado pela fonte de dados.
P/VP
1,65
Compara o preço de mercado de uma ação ou cota com o valor contábil/patrimonial por ação ou cota (VPA).
Dividend Yield
6,88%
Percentual pago em proventos nos 365 dias anteriores ao cálculo em relação ao preço usado na coleta.
ROE
8,99%
Relação entre o lucro atribuível aos controladores e o patrimônio líquido atribuível aos controladores.
Net Margin
12,42%
De cada R$ 1,00 de receita, quanto sobra como lucro depois de todos os custos, despesas e impostos.
Net Debt / EBITDA
—
Relação entre a dívida líquida e o EBITDA de uma empresa.
EPS
US$ 1,36
Valor de lucro por ação informado pela fonte de dados da empresa.
BVPS
US$ 15,17
Quanto do patrimônio contábil da empresa (ou do fundo) corresponde a cada ação ou cota.
Reference: 31/12/2025 · All indicators: Financial Modeling Prep (FMP)
Income history
Recent dividends
| Type | Ex-date | Payment date | Value/share |
|---|---|---|---|
| dividendo | — | 01/09/2026 | US$ 0,43 |
| dividendo | — | 12/06/2026 | US$ 0,43 |
| dividendo | — | 06/03/2026 | US$ 0,43 |
| dividendo | — | 01/12/2025 | US$ 0,43 |
| dividendo | — | 02/09/2025 | US$ 0,43 |
| dividendo | — | 13/06/2025 | US$ 0,43 |
| dividendo | — | 07/03/2025 | US$ 0,43 |
| dividendo | — | 02/12/2024 | US$ 0,42 |
| dividendo | — | 03/09/2024 | US$ 0,42 |
| dividendo | — | 14/06/2024 | US$ 0,42 |
Context
About Pfizer Inc.
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.